SUBSCRIBE
SUBSCRIBE
News   Deals

Pfizer Inc. Eyes Germany’s MediGene, Inc. According to Sources

May 14, 2008 | 
1 min read
FRANKFURT, May 14 (Reuters) - U.S. drugmaker Pfizer is exploring acquisition possibilities in the German biotech sector and has held talks with the management of Munich-based MediGene, two industry sources said.
Mergers & acquisitions Europe
Pfizer
MORE ON THIS TOPIC
Facade of Novo Nordisk's office in Fremont, California
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Pictured: Bristol Myers Squibb office in California
ALS
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line
October 15, 2025
 · 
1 min read
 · 
Tristan Manalac
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Mergers & acquisitions
BioCryst Snaps Up Fellow Angiodema Player Astria for $700M
October 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Q3 Earnings Are Here, Novo Ditches Cell Therapy but Buys Akero, Gov’t Shutdown Hits CDC
October 15, 2025
 · 
1 min read
 · 
Heather McKenzie